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Abstract 
The dietary inflammatory index (DII) is a new tool to assess the inflammatory potential 
of diet. We aimed to determine the association between the DII and body mass index 
(BMI), waist circumference and waist to height ratio (WHtR). We conducted a cross-
sectional study of 7,236 participants recruited into the PREDIMED trial (PREvención 
con DIeta MEDiterránea). Information from a validated 137-item food frequency 
questionnaire was used to calculate energy, foods and nutrients. A 14-item dietary 
screener was used to assess adherence to the Mediterranean diet (MeDiet). Sex-specific 
multivariable linear regression models were fitted to estimate differences (and 95% 
confidence intervals) in BMI, waist circumference and WHtR across quintiles of the DII. 
All nutrient intakes, healthy foods and adherence to the MeDiet were higher in the 
quintile with lowest DII score (more anti-inflammatory values) except for animal 
protein, saturated and monounsaturated fat. Though an inverse association between DII 
and total energy was apparent, the DII was associated with higher average BMI, waist 
circumference and WHtR after adjusting for known risk factors. The adjusted difference 
in WHtR for women and men between the highest and lowest quintile of DII was 1.60% 
(95% CI 0.87-2.33) and 1.04% (95% CI 0.35-1.74), respectively. Pro-inflammatory 
scores remained associated with obesity after controlling for the effect that adherence to 
a MeDiet had on inflammation. In conclusion, this study shows a direct association 
between the DII and indices of obesity and supports the hypothesis that diet may have a 
role in the development of obesity through inflammatory modulation mechanisms. 
 
Trial Registration International Standard Randomised Controlled Trial Number 
Registry ISRCTN35739639 
 4
 
Introduction 
The obesity pandemic constitutes a major public health problem in most high-income 
countries and it is emerging as a threat in more affluent sectors of developing 
countries(1). In 2008 more than 10% of the World's adult population, i.e. around 500 
million people, were obese according to the WHO(2). It is estimated that 3.4 million 
adult deaths worldwide were in 2010 attributable to obesity or overweight(1). This is a 
global crisis since 65% of the world's population live in countries where overweight and 
obesity kill more people than underweight(2). 
Obesity is the result of the accumulation of excess body fat and it is often characterized 
as a state of low-grade chronic inflammation(3). This obesity-induced inflammation has 
multi-organ metabolic effects affecting adipose tissue, liver, muscle, pancreas and 
brain(4). Metabolic differences exist according to the location of the fat cells. For 
example, excessive deposition of fat in visceral adipose tissue (i.e., intra-abdominal fat) 
is associated with higher health risks than subcutaneous fat accumulation in the 
extremities(5). In fact, different anthropometric adiposity measures including waist 
circumference or waist to height ratio (WHtR) are used to assess the role of adiposity in 
cardiovascular disease risk(6,7). 
A number of studies have shown an association between diet and inflammatory 
biomarkers and how this translates into increased or decreased risk of chronic metabolic 
diseases(8-15). Part of the preventive role of healthy dietary patterns, such as the 
Mediterranean diet, could be attributed to the anti-inflammatory properties of some of 
their main components(15-19). This anti-inflammatory effect may decrease the low-grade 
inflammation usually found in obese patients(20,21). However, a Mediterranean diet may 
also attenuate inflammation in the absence of weight loss(22). A recent hypothesis is that 
obesity could be also partly the consequence of a previous chronic low grade 
inflammation and, therefore, a bidirectional association between inflammation and 
obesity may exist(23). 
Consequently, it can be useful to characterize an individual’s diet according to its 
inflammatory properties in order to investigate the inflammatory links between obesity 
and diet(24). The dietary inflammatory index (DII) is a new tool to assess this 
inflammatory potential of the diet(25). In this article we examine the relationships 
between nutrient intake or food group consumption and the DII as well as the 
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association between the DII and indices of both general and abdominal obesity in the 
PREDIMED trial.  
Methods 
Ethics statement 
The protocol was approved by the Research Ethics Committees at all recruiting centers: 
University of Navarra, University of Valencia, University Rovira i Virgili, IMIM-
Hospital del Mar Medical Research Institute, University of Barcelona, University 
Hospital of Alava, University of Malaga, University of Balearic Islands, University of 
Las Palmas de Gran Canaria, University Hospital of Bellvitge, Hospital Clinic.  
Participants signed a written informed consent. 
 
Study design and participants 
The “PREvención con DIeta MEDiterránea” (PREDIMED) study was a parallel group, 
multicenter, clinical trial that aimed to assess the effects of the traditional MedDiet on 
the primary prevention of cardiovascular disease (protocol available at 
www.predimed.es). A detailed description of methods and patients has been published 
elsewhere(26,27). The study was conducted between October 2003 and December 2010 by 
11 recruiting centers in Spain.  
Eligible participants were men 55 to 80 years of age and women 60 to 80 years of age 
with no previous cardiovascular disease. At baseline, participants should have a 
diagnosis of type 2 diabetes mellitus or at least three of the following major 
cardiovascular risk factors: smoking (more than 1 cig/day during the last month), 
hypertension (systolic blood pressure ≥ 140 mm Hg or diastolic blood pressure ≥ 90 mm 
Hg or antihypertensive medication), elevated low-density lipoprotein cholesterol levels 
(≥ 160 mg/dl), low high-density lipoprotein cholesterol levels (≤ 40 mg/dl in men or ≤ 
50 mg/dl in women, independently of lipid-lowering therapy), BMI ≥ 25 kg/m2, or a 
family history of premature coronary heart disease.  
A total of 7447 participants were randomized in a 1:1:1 ratio to a parallel-design 
intervention trial of dietary advice: a) a MedDiet supplemented with extra-virgin olive 
oil, b) a MedDiet supplemented with nuts, or c) advice to follow a low-fat diet (control 
group). Medical conditions and risks factors related to eligibility were collected with a 
questionnaire during the first screening visit. Participants, with the assistance of trained 
dietitians, completed a food frequency questionnaire (FFQ). This FFQ was adapted from 
the Willett questionnaire and validated in Spain(28). It includes 137 items plus 
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vitamin/minerals supplements and with specific questions for patterns of alcohol 
consumption. Energy and nutrient intakes were calculated from Spanish food 
composition tables(29). Participants also completed the Spanish validated version of the 
Minnesota physical activity questionnaire(30), and a 14-item dietary screener to assess 
adherence to the MedDiet(31). PREDIMED dietitians were responsible for the accurate 
completion of the questionnaires. 
For the present study, 133 participants were excluded from the analyses because they 
reported values for total energy intake outside of the predefined limits (<800 or >4200 
kcal/d for men and <600 or >3500 kcal/d for women). These limits were set in 
accordance with those recommended by Willett in Nutritional Epidemiology(32). Another 
78 participants were excluded because of lack of information on the FFQ needed to 
calculate the DII.  
 
The Dietary Inflammatory Index (DII)  
The design and development of the DII has been described elsewhere(25). Briefly, the DII 
is a scoring algorithm based on an extensive review of the literature published from 
1950 to 2010 linking 1943 articles to a total of forty-five food parameters including 
various macronutrients, micronutrients, flavonoids and food items (figure 1). These 
dietary parameters were scored according to whether they increased (+1), decreased (-1) 
or had no effect (0) on six inflammatory biomarkers (IL-1β, IL-4, IL-6, IL-10, TNF-α 
and C-reactive protein). An overall food parameter-specific inflammatory effect score 
was calculated and multiplied by a centered percentile value for each food. This 
percentile was calculated by first linking the dietary data from a study to the regionally 
representative world database intake which was based on actual human consumption in 
11 populations from different parts of the world that provided a robust estimate of a 
mean and standard deviation for each parameter. These then become the multipliers to 
express an individual’s exposure relative to the “standard global mean” as a z-score. 
This was achieved by subtracting the “standard global mean” from the amount reported 
and dividing this value by the standard deviation. To minimize the effect of “right 
skewing”, this value was then converted to a centered percentile score. The centered 
percentile score for each food parameter for each individual was multiplied by the 
respective food parameter effect score, which was derived from the literature review, in 
order to obtain a food parameter-specific DII score for an individual. All of the food 
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parameter-specific DII scores were then summed to create the overall DII score for 
every participant in the study. The greater the DII score, the more pro-inflammatory the 
diet and more negative values represent more anti-inflammatory diets. The DII score 
could take on values ranging from 7.98 (maximally pro-inflammatory) to -8.87 
(maximally anti-inflammatory)(25). 
Construct validation of the DII was performed using data derived from two different 
sources of dietary intake information and serum high-sensitivity C-reactive protein as 
the construct validator(33).  
 
Outcome 
Trained and certified PREDIMED nurses performed all baseline anthropometric 
adiposity measures including weight and height [from which BMI (kg/m2) was 
computed], waist circumference (cm) and WHtR (%) following validated procedures. A 
waist-to-height ratio equal to 1 was taken as 100%. Baseline weight was measured using 
a calibrated balance beam scale with the subject barefoot and wearing light clothes. The 
nurse measured height using a wall-mounted calibrated stadiometer. Waist 
circumference was measured using an anthropometric measuring tape, at a horizontal 
plane midway between the lowest rib and the iliac crest.  
 
Statistical analysis 
Statistical analyses were stratified by sex. Comparisons of quantitative variables across 
quintiles of the DII were done using one-way ANOVA. The compared variables 
included total energy intake, physical activity and nutrient and food consumption. 
Intakes of carbohydrate, protein and fat (and fat subtypes) were expressed as 
percentages of total energy intake (Table 1). Categorical variables were compared using 
the Pearson Chi-squared test.  
Sex-specific least-squared means of BMI, waist circumference and WHtR were 
estimated across quintiles of DII. Pearson correlation coefficients (and 95% confidence 
intervals) between these anthropometric adipose measures and the DII index were also 
calculated. 
Sex-specific multiple linear regression models were used to estimate the differences 
(95% confidence intervals) in the indices of general obesity and abdominal obesity 
according to quintiles of the DII. Covariates included in these models were age (years), 
smoking status (never, current or former smoker), diabetes (yes or no), hypertension 
 8
(yes or no), leisure-time physical activity (MET-min/d), educational level 
(illiterate/elementary education, secondary education or university), marital status 
(married, widowed, single or other), total energy intake (kcal/d), and research center. In 
addition, tests of linear trend across successive quintiles of DII index were conducted 
using the median value for each quintile category as a continuous variable and after 
adjusting for the confounding variables mentioned above.  
Residuals of the DII were obtained in a linear regression analysis of the association 
between the DII and a previously validated 14-item PREDIMED screener of adherence 
to the MeDiet.(31) These residuals represent the information provided by the DII that is 
not explained at all by adherence to the MeDiet (i.e. they exhibit zero correlation with 
the MeDiet score). They were included as an independent variable after transformation 
into quintiles in a multivariable regression model with the same covariates previously 
listed (residual model).  
All P values presented are 2-tailed and differences were considered statistically 
significant at p ≤ 0.05. All statistical analyses were carried using the STATA® software 
for Windows version 12.0. 
 
Results 
A total number of 7236 participants out of the 7447 initially randomized subjects in the 
PREDIMED trial were included in this study. The 211 (2.8%) remaining participants 
were excluded because of incomplete data on their FFQs (n=78) or baseline energy 
intake out of predefined values (n=133). Among the 7236 participants, 57% were 
women. The mean age of participants was 68 (±5.8) years for women and 66 (±6.6) 
years for men. The median DII score for women was -0.78 (from -4.90 to 3.68) and -
0.91 (from -5.23 to 3.69) for men.  
Table 1 shows the main characteristics of participants according to categories of the DII 
score by sex. All differences between quintiles of this index were statistically significant 
among women except for the percentage of subjects with a family history of early CHD, 
the presence of hypertension and the smoking status. Among men, differences between 
quintiles of DII according to age, hypertension, diabetes and smoking were not 
statistically significant. In both sexes, the level of physical activity was inversely 
associated with the DII as was total energy intake and alcohol intake.  
All macro- and micronutrient intakes were higher in the quintile with lowest DII score 
(anti-inflammatory dietary pattern) except for intakes of animal protein, saturated fat 
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and monounsaturated fat, both among women and men (Table 2). Better adherence to a 
MeDiet also was associated with lower DII scores.  
Table 3 shows the adjusted indices of obesity based on BMI, waist circumference and 
WHtR according to the DII score stratified by sex. The lower and upper limits of this 
score are shown for each quintile. Mean values of all three adiposity indices increased 
linearly across successive quintiles of DII scores (from anti-inflammatory to pro-
inflammatory levels). A significant positive correlation was observed between these 
obesity indexes and the DII score.  
Among women, the DII was directly associated with BMI after adjusting for multiple 
factors related to obesity (table 4). Being in the highest quintile of the DII was 
associated with an increase of 0.79 kg/m2 in the BMI (95%CI, 0.35-1.23) compared with 
the lowest quintile (p for trend = 0.001). This association was not statistically significant 
for men.  
Waist circumference and WHtR increased progressively across quintiles 2 to 4 and 5 
compared with the lowest quintile of DII, both in women and men (p for trend 
statistically significant in all comparisons).  
Table 5 shows the association of the DII with the anthropometric indices after 
considering the possible contribution of the Mediterranean diet elements to the anti- or 
pro-inflammatory capacity of the diet. A higher pro-inflammatory level of diet (beyond 
the effect of lower adherence to the MeDiet) was associated with higher adjusted means 
of BMI, waist circumference and WHtR (p for trend < 0.05 in all comparisons except for 
BMI among men). The predicted increase in anthropometric measures was statistically 
significant in women except for the increase in BMI and in WHtR when the intermediate 
DII quintiles (2 to 4) were compared with the lowest category. On the contrary, results 
were not statistically significant among men except for the waist circumference and the 
WHtR when comparing the highest versus the lowest quintile of the residuals of DII.  
 
Discussion 
In our study, we used a score (DII) to appraise the capacity of the overall dietary pattern 
to promote inflammation. Higher values of DII represent a higher inflammatory 
potential. As expected, we observed that DII was inversely associated with the intake of 
healthy foods, nutrients and adherence to MeDiet. A pro-inflammatory DII was directly 
associated with indices of general and abdominal obesity, independent of established 
risk factors for obesity including total energy intake, age, smoking, diabetes, 
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hypertension, physical activity, educational level and marital status. These results were 
consistent for both sexes except for the BMI in men. In the residual model (after 
removing the variability explained by MeDiet), the association between the 
inflammatory potential of the diet and higher adiposity indices remained apparent, but 
there was a clearer association between the DII and the abdominal indices of obesity for 
women than for men. 
The associations observed between nutrient intake or food consumption with the DII are 
consistent with previous research. Several studies have shown an inverse association 
between healthy diets and markers of inflammation as well as a direct association with 
“Western-like” dietary patterns(8-14). Specifically, a lower C-reactive protein 
concentration has been associated with higher intake of fruits and vegetables(34-36), 
legumes(37), nuts(38), and low-fat dairy consumption(39). Previous studies also have 
observed associations of specific nutrients such as total dietary fiber intake(40), moderate 
alcohol consumption(41), vitamin E and vitamin C intake(42) with lower levels of 
inflammation markers. On the contrary, animal protein seems to increase the 
inflammatory status of obese individuals(43). 
We also found that a higher consumption of dairy products and meat (or meat products) 
was less frequent in the highest DII quintile. A systematic review has found no impact of 
dairy products consumption on biomarkers of inflammation on overweight and obese 
adults(44). However, only 1 out of 8 trials included in this review defined inflammation 
as its primary outcome and there were some methodological limitations in them such as 
insufficient statistical power(44). Concerning the consumption of meat, a cross-sectional 
analysis of data from 3690 diabetes-free female participants found that higher intake of 
meat protein was associated with higher plasma levels of inflammatory markers(45). 
However, a cross-sectional study has shown that the association between red meat intake 
and inflammatory markers was no longer observed after adjustment for BMI(46). 
Therefore, it is suggested that the association between red meat intake and inflammation 
is probably mediated by obesity.   
In our study, a higher pro-inflammatory diet was observed in participants with higher 
BMI, waist circumference and WHtR. This result suggests the hypothesis that a diet-
induced inflammation might be contributing to increase or maintain obesity, especially 
abdominal obesity, in a population that is mostly overweight or obese. The origin of 
inflammation during obesity is not yet fully understood. It is acknowledged that 
inflammation is induced by adiposity(4,5), but this relationship can be bidirectional (i.e., a 
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pro-inflammatory diet can increase or maintain adiposity), thus creating a vicious circle, 
because nutrient excess and some specific foods or nutrients also have been associated 
with inflammation(47). The potential mechanisms underlying this association is the 
activation of pathogen-associated molecular patterns, such as toll-like receptors and nod-
like receptors, which induce the activation of inflammatory markers in several tissues 
including the adipose tissue(48). Moreover, dietary patterns (e.g., high-fat/low-fiber or 
low-fat/high-fiber diet) and single specific nutrients (e.g., dietary fiber) appear to have 
important consequences in the gut microbiota which is also involved in the low-grade 
inflammation associated with obesity(49-52). 
The residuals of the DII (from a regression model on adherence to the Mediterranean 
diet) were also associated with obesity indices. These residuals represent the information 
provided by the DII about the anti- or pro-inflammatory capacity of a diet that could not 
be explained by adherence to the Mediterranean diet. A highest pro-inflammatory diet 
showed a stronger association with waist circumference than with other anthropometric 
indices, both among women and men. These results are in close agreement with 
previous findings showing that central adiposity-related indices are more strongly 
correlated with plasma pro-inflammatory markers than indices assessing total adiposity 
in healthy young adults(5). Moreover, abdominal adiposity has been associated with 
elevated CRP levels independent of BMI in older adults(53). As a consequence, our 
results are reinforcing the usefulness of the DII to assess the inflammatory properties of 
a diet and the association between inflammation and central obesity indices.   
Our results are also consistent with those of studies reporting a stronger association of 
CRP and BMI in women than in men(54,55) This between-sexes difference could be 
partially explained by a greater accumulation of subcutaneous fat in women than in men 
and higher lean mass in men(55). Sex differences in the metabolic activity of adipose 
tissues as well as in the association between leptin and CRP may also explain these 
differences(56,57).  
The strengths of the current study include a large sample size, the use of a validated 
instrument to measure the inflammatory potential of the diet, the adjustment for a large 
number of factors associated with obesity, the detailed measures of obesity indexes and 
the validation of all assessment instruments including the MedDiet screener, the FFQ, 
and the physical activity questionnaire. This study also has limitations, the main of 
which is the cross-sectional nature of our analyses. It is therefore unclear whether obese 
individuals are more likely to choose pro-inflammatory diets or if pro-inflammatory 
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diets contribute to promote or maintain obesity. Both weight reduction and an overall 
healthy dietary pattern have the capacity to reduce inflammatory markers. Thus, the 
association between the DII and obesity indices remains to be confirmed in prospective 
analyses. Another limitation is that anthropometric measures are surrogate markers of 
abdominal obesity(Eroglu, Tagawa & Somlo 2014). Waist circumference and WHtR do 
not differentiate between visceral adipose tissue and subcutaneous abdominal adipose 
tissue(58). Therefore, we cannot determine whether the DII is more strongly associated 
with visceral, subcutaneous or both types of abdominal fat mass. Finally, the DII is 
limited by current knowledge of the inflammatory factors involved in obesity. However, 
the DII has been found to be associated with inflammatory cytokines including C-
reactive protein and interleukin-6(33,59,60), the glucose intolerance component of the 
metabolic syndrome(59), and the odds of asthma and of reduced FEV1 in an Australian 
population(60). It has been also reportedly associated with a higher risk of colorectal 
cancer(61), prostate cancer(62) and pancreatic cancer(63).  
In conclusion, the current findings indicate an association between anti-inflammatory 
values of the DII and healthy foods, nutrients and higher adherence to MeDiet. A pro-
inflammatory diet was associated with elevated indices of central and abdominal 
obesity. This association suggest that the DII may have the capacity to help elucidate the 
role that diet plays in the development of obesity through inflammatory processes. 
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